Oruka Therapeutics Inc. (ORKA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Oruka Therapeutics Inc.

    NASDAQ: ORKA · Real-Time Price · USD
    19.79
    0.61 (3.18%)
    At close: Oct 03, 2025, 3:59 PM
    19.40
    -1.97%
    After-hours: Oct 03, 2025, 05:53 PM EDT

    Oruka Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 27K 111K 114K 91K
    Gross Profit
    		 -27K -111K -114K -91K
    Operating Income
    		 -88.12M -7.3M -9.84M -19.34M
    Interest Income
    		 5.86M 1.96M 675K n/a
    Pretax Income
    		 -83.72M -5.34M -9.93M -19.32M
    Net Income
    		 -83.72M -5.34M -9.93M -19.32M
    Selling & General & Admin
    		 13.04M 6.17M 5.26M 5.41M
    Research & Development
    		 75.06M 1.01M 4.46M 13.83M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 88.1M 7.18M 9.73M 19.24M
    Interest Expense
    		 1.47M n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 88.12M 7.3M 9.84M 19.34M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 16.79M 14.42M 14.41M 13.9M
    Shares Outstanding (Diluted)
    		 16.79M 14.42M 14.41M 13.9M
    EPS (Basic)
    		 -4.99 -4.44 -8.27 -16.68
    EPS (Diluted)
    		 -4.99 -4.44 -8.27 -16.68
    EBITDA
    		 -82.23M -5.23M -9.81M -19.23M
    EBIT
    		 -82.26M -5.34M -9.93M -19.32M
    Depreciation & Amortization
    		 27K 111K 114K 91K

    Add to Watchlist